Cargando…
Erratum to: ‘TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial’
Autores principales: | Morris, Dylan R., Cunningham, Margaret A., Ahimastos, Anna A., Kingwell, Bronwyn A., Pappas, Elise, Bourke, Michael, Reid, Christopher M., Stijnen, Theo, Dalman, Ronald L., Aalami, Oliver O., Lindeman, Jan H., Norman, Paul E., Walker, Philip J., Fitridge, Robert, Bourke, Bernie, Dear, Anthony E., Pinchbeck, Jenna, Jaeggi, Rene, Golledge, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721016/ https://www.ncbi.nlm.nih.gov/pubmed/26791257 http://dx.doi.org/10.1186/s13063-016-1183-x |
Ejemplares similares
-
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial
por: Morris, Dylan R., et al.
Publicado: (2015) -
Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial
por: Rowbotham, Sophie E., et al.
Publicado: (2017) -
Randomized Placebo‐Controlled Trial Assessing the Effect of 24‐Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME‐2 Trial
por: Pinchbeck, Jenna L., et al.
Publicado: (2018) -
Short report: Experiences of Caregivers Participating in a Telehealth Evaluation of Development for Infants (TEDI)
por: Talbott, Meagan R., et al.
Publicado: (2022) -
Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022)